Stocksigma LogoStocksigma Logo

Senores Pharmaceuticals Schedules Board Meeting on 29th Oct'26 for Q2 Results

Senores Pharmaceuticals Limited announced that its Board of Directors will meet on 29th Oct'26 to consider and approve the un-audited standalone and

Senores Pharmaceuticals Schedules Board Meeting on 29th Oct'26 for Q2 Results

Senores Pharmaceuticals Ltd 路 Intimation 路 29 Oct 2026, 5:30 am

Senores Pharmaceuticals Schedules Board Meeting on 29th Oct'26 for Q2 Results Senores Pharmaceuticals Limited announced that its Board of Directors will meet on 29th Oct'26 to consider and approve the un-audited standalone and consolidated financial results for the quarter and half-year ended 30th Sep'26. Additionally, the trading window for dealing in company securities has been closed since 1st Oct'26 and will reopen 48 hours after the financial results are approved and submitted to stock exchanges.

Original exchange filing (PDF)

More announcements from Senores Pharmaceuticals Ltd

All Senores Pharmaceuticals Ltd announcements